Savara (SVRA) Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization
Savara Inc. faces a funding shortage and a dependence on a single clinical trial. Simultaneously, the company is implementing energy-saving systems and chemical reagent disposal in accordance with ESG standards. The EV/EBITDA multiple trajectory reflects the market reaction to news, where the 0.00 mark indicates the current state. Growth prospects are based on the completion of the development of an innovative inhaler for the therapy of rare lung pathologies.
savarapharma.com - analytical breakdowns and key metrics (SVRA)
- current price and projected stock value:
- market capitalization details:
- book value of equity indicators:
- debt level and financial liquidity data:
- business earnings and investment ratios data:
SVRA - Company Net Income|Projected Future Earnings Savara Inc.|SVRA - P/E Multiple|Future Price to Earnings Savara Inc.|SVRA - Growth-Adjusted Payback Ratio|EV/EBITDA Multiple Savara Pharma|SVRA - Operating profit EBITDA|Net earnings per share for the last 12 months Savara|SVRA - Earnings per share for the trailing year|Quarterly EPS earnings growth savarapharma.com|SVRA - Expected net earnings per share growth this year|Net earnings per share growth forecast for next year Savara Inc.
Initial company analysis:SVRA (Savara Corp)
For Savara Inc. (SVRA), whose model is based on costly clinical trials with high margins following drug approval, the EV/EBITDA debt and operating leverage metric serves as an indicator of capitalization efficiency. This metric correlates the total enterprise value (equity plus debt minus cash) with operating profit, allowing investors to assess the asset payback period and the resilience of capital against debt obligations.
Analysis of competing companies
EV/EBITDA Multiple ARGX (Argenx)|Total Company Value to Operating Income Before Depreciation Ratio BioNTech Pharma (BNTX)|ABVX - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|admabiologics.com (ADMA) - Enterprise Value to EBITDA Ratio|Protagonist (PTGX) - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Enterprise Value to EBITDA Ratio Immunovant Inc|Enterprise Value to EBITDA Ratio KNSA|EV/EBITDA Multiple Grifols Biemat|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Adaptive Biotechnologies (ADPT)|celldex.com - Enterprise Value to Operating Income Before Depreciation|EV/EBITDA Multiple AUPH (Aurinia Pharmaceuticals Inc.)|BioCryst Pharmaceuticals, Inc. (BCRX) - Company Value to EBITDA|VERA - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Total Company Value to Operating Income Before Depreciation Ratio Dianthus Corp DNTH|PHVS: EV/EBITDA Multiple|AbCellera (ABCL) - EV/EBITDA Multiple|Enterprise Value to EBITDA Ratio TRML|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization PGEN|EV/EBITDA Multiple PHAR|EV/EBITDA Multiple Nektar Corp (NKTR)|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Upstream Bio Inc UPB|Business Value to Operating Income Before Depreciation ZBIO|Immunome - EV/EBITDA Multiple|GOSS - EV/EBITDA Multiple|KALV (KalVista Pharmaceuticals Inc) - Enterprise Value to EBITDA Ratio|Septerna Pharma - Business Value to Operating Income Before Depreciation|PVLA (Pieris Pharmaceuticals) - EV/EBITDA Multiple|rigel.com (RIGL) - Total Company Value to Operating Income Before Depreciation Ratio|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization AnaptysBio (ANAB)|Astria Therapeutics Inc - Enterprise Value to Operating Income Before Depreciation|EV/EBITDA Multiple ENGN (enGene Bio)|RAPT - Enterprise Value to EBITDA Ratio|JBIO: Enterprise Value to EBITDA Ratio|Total Company Value to Operating Income Before Depreciation Ratio aclaristx.com ACRS|Kyverna Therapeutics, Inc. (KYTX) - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|TLSA - Total Company Value to Operating Income Before Depreciation Ratio|Enterprise Value to EBITDA Ratio CABA|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization VTYX|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Theratechnologies Inc. (THTX)|AVTX (avalotx.com) - Business Value to Operating Income Before Depreciation|EV/EBITDA Multiple ELDN (Eledon Pharmaceuticals, Inc.)|EV/EBITDA Multiple Agenus, Inc. AGEN|CLYM - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Company Value to Operating Income Before Depreciation Ratio ZURA|ATYR: EV/EBITDA Multiple|Adagene Inc. - Business Value to Operating Income Before Depreciation|IMA (ImageneBio) - EV/EBITDA Multiple|EV/EBITDA Multiple Shattuck Therapeutics|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Equillium, Inc. (EQ)|CNTB (connectbiopharm.com) - Business Value to Operating Income Before Depreciation|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Immunic IMUX|ATRA - Enterprise Value to EBITDA Ratio|InflaRx GmbH - EV/EBITDA Multiple|XFOR - EV/EBITDA Multiple|ACET (adicetbio.com) - Enterprise Value to EBITDA Ratio|Celularity - Business Value to Operating Income Before Depreciation|INMB (INmune Bio, Inc.) - EV/EBITDA Multiple|barinthusbio.com (BRNS) - Total Company Value to Operating Income Before Depreciation Ratio|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Kezar Life Sciences, Inc. (KZR)|Enterprise Value to EBITDA Ratio SAB Biotherapeutics Inc. SABS|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Akari Therapeutics plc AKTX|ENLV - Enterprise Value to EBITDA Ratio|QTTB: Enterprise Value to EBITDA Ratio|GOVX - EV/EBITDA Multiple|Edesa Biotech (EDSA) - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Enterprise Value to Operating Income Before Depreciation IBIO|CARM (Carisma Therapeutics Inc) - EV/EBITDA Multiple|Company Value to EBITDA XTL Bio XTLB|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Bolt Biotherapeutics (BOLT)|Total Company Value to Operating Income Before Depreciation Ratio hcwbiologics.com|EV/EBITDA Multiple APVO (Aptevo Therapeutics Inc.)|EV/EBITDA Multiple aimimmuno.com AIM|ADTX: Enterprise Value to EBITDA Ratio|GRI: Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|XRTX: EV/EBITDA Multiple|reshapelifesciences.com (HIND) - EV/EBITDA Multiple|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Revelation Biosciences, Inc.|INDP: Business Value to Operating Income Before Depreciation|EV/EBITDA Multiple SCNI|EV/EBITDA Multiple calcimedica.com (CALI)|Affimed N.V. - Enterprise Value to EBITDA Ratio|Business Value to Operating Income Before Depreciation ALLK|HOOKIPA - EV/EBITDA Multiple|Total Company Value to Operating Income Before Depreciation Ratio IGM Biosciences, Inc. IGMS|iTeos (ITOS) - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Enterprise Value to Operating Income Before Depreciation OCEA|TCBP (TC Biopharm) - EV/EBITDA Multiple|Enterprise Value to EBITDA Ratio thirdharmonicbio.com (THRD)
